Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice

被引:38
|
作者
Li, Xia [1 ]
Risbrough, Victoria B. [1 ,4 ]
Cates-Gatto, Chelsea [2 ]
Kaczanowska, Katarzyna [3 ]
Finn, M. G. [3 ]
Roberts, Amanda J. [2 ]
Markou, Athina [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA
[2] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[4] Vet Affairs Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA
基金
美国国家卫生研究院;
关键词
GABA(B) receptor; Positive allosteric modulator; Anxiety; Learning; Memory; GAMMA-AMINOBUTYRIC-ACID; VOGEL CONFLICT TEST; ELEVATED PLUS-MAZE; ALLOSTERIC MODULATOR; ANIMAL-MODELS; MOTIVATIONAL PROPERTIES; WORKING-MEMORY; SPATIAL MEMORY; WATER MAZE; GS39783;
D O I
10.1016/j.neuropharm.2013.01.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
gamma-Arninobutyric acid B (GABA(B)) receptor activation is a potential therapeutic approach for the treatment of drug addiction, pain, anxiety, and depression. However, full agonists of this receptor induce side-effects, such as sedation, muscle relaxation, tolerance, and cognitive disruption. Positive allosteric modulators (PAMs) of the GABA(B) receptor may have similar therapeutic effects as agonists with superior side-effect profiles. The present study behaviorally characterized N-([1R,2R,4S]-bicyclo[2.2.1]hept-2-yl)-2-methyl-5-(4-[trifluoromethyl]phenyl)-4-pyrimidinamine (BHF177), a GABA(B) receptor PAM, in mouse models of anxiety-like behavior, learning and memory. In addition, the effects of BHF177 were compared with the agonist baclofen. Unlike the anxiolytic chlordiazepoxide, baclofen (0.5, 1.5, and 2.5 mg/kg, intraperitoneally) and BHF177 (10, 20, and 40 mg/kg, orally) had no effect on anxiety-like behavior in the elevated plus maze, light/dark box, or Vogel conflict test. Baclofen increased punished drinking in the Vogel conflict test, but this effect may be attributable to the analgesic actions of baclofen. At the highest dose tested (2.5 mg/kg), baclofen-treated mice exhibited sedation-like effects (i.e., reduced locomotor activity) across many of the tests, whereas BHF177-treated mice exhibited no sedation-like effects. BHF177 exhibited pro-convulsion properties only in mice, but not in rats, indicating that this effect may be species-specific. At doses that were not sedative or pro-convulsant, baclofen and BHF177 had no selective effects on fear memory retrieval in contextual and cued fear conditioning or spatial learning and memory in the Barnes maze. These data suggest that BHF177 has little sedative activity, no anxiolytic-like profile, and minimal impairment of learning and memory in mice. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:156 / 167
页数:12
相关论文
共 50 条
  • [21] Operant, oral alcoholic beer self-administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABAB receptors
    Orru, Alessandro
    Fujani, Daniele
    Cassina, Chiara
    Conti, Mirko
    Di Clemente, Angelo
    Cervo, Luigi
    PSYCHOPHARMACOLOGY, 2012, 222 (04) : 685 - 700
  • [22] EVALUATION OF THE EFFECTS OF THE GABA-B RECEPTOR POSITIVE MODULATOR BHF177 ON NICOTINE SELF-ADMINISTRATION IN HIGH AND LOW IMPULSIVE RATS
    Vlachou, Styliani
    Campos, Angelica
    Kaczanowska, Katarzyna
    Finn, M. G.
    Markou, Athina
    BEHAVIOURAL PHARMACOLOGY, 2013, 24 : E27 - E27
  • [23] Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction
    Vengeliene, Valentina
    Takahashi, Tatiane T.
    Dravolina, Olga A.
    Belozertseva, Irina
    Zvartau, Edwin
    Bespalov, Anton Y.
    Spanagel, Rainer
    PSYCHOPHARMACOLOGY, 2018, 235 (07) : 1955 - 1965
  • [24] Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction
    Valentina Vengeliene
    Tatiane T. Takahashi
    Olga A. Dravolina
    Irina Belozertseva
    Edwin Zvartau
    Anton Y. Bespalov
    Rainer Spanagel
    Psychopharmacology, 2018, 235 : 1955 - 1965
  • [25] The effects of intraperitoneal administration of the GABAB receptor agonist baclofen on food intake in CFLP and C57BL/6 mice
    Ebenezer, Ivor S.
    Prabhaker, Monika
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 569 (1-2) : 90 - 93
  • [26] Anti-proliferative and anti-inflammatory effects of the application of baclofen cream, a GABAB receptor agonist, on skin inflammation in mice
    Oliveira, Vitor Helio de Souza
    Amorim, Mayara Alves
    de Oliveira, Janiana Raiza Jentsch Matias
    Soley, Bruna Silva
    Rocha, Fernanda Grillo
    Bandenburg, Margareth de Mello
    Lejeune, Vanessa Bordenowsky Pereira
    Silva, Alvaro Henrique Bernardo de Lima
    Witherden, Deborah A.
    Havran, Wendy L.
    Zanoveli, Janaina Menezes
    Cabrini, Daniela Almeida
    Calixto, Joao Batista
    Otuki, Michel Fleith
    Andre, Eunice
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 955
  • [27] The GABAB receptor agonist, baclofen, and the positive allosteric modulator, CGP7930, inhibit visceral pain-related responses to colorectal distension in rats
    Martinez, V.
    Brusberg, M.
    Ravnefjord, A.
    Martinson, R.
    Kakol-Palm, D.
    Pahlman, I.
    Noven, A.
    Larsson, H.
    Lindstrom, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 18 - 18
  • [28] The GABAB receptor agonist, baclofen, and the positive allosteric modulator, CGP7930, inhibit visceral pain-related responses to colorectal distension in rats
    Brusberg, Mikael
    Ravnefjord, Anna
    Martinsson, Rakel
    Larsson, Hakan
    Martinez, Vicente
    Lindstrom, Erik
    NEUROPHARMACOLOGY, 2009, 56 (02) : 362 - 367
  • [29] Reduced Fear Memory and Anxiety-like Behavior in Mice Lacking Formylpeptide Receptor 1
    Gao, Ji-Liang
    Schneider, Erich H.
    Dimitrov, Eugene L.
    Haun, Forrest
    Pham, Therese M.
    Mohammed, Abdul H.
    Usdin, Ted B.
    Murphy, Philip M.
    BEHAVIOR GENETICS, 2011, 41 (05) : 724 - 733
  • [30] Reduced Fear Memory and Anxiety-like Behavior in Mice Lacking Formylpeptide Receptor 1
    Ji-Liang Gao
    Erich H. Schneider
    Eugene L. Dimitrov
    Forrest Haun
    Therese M. Pham
    Abdul H. Mohammed
    Ted B. Usdin
    Philip M. Murphy
    Behavior Genetics, 2011, 41 : 724 - 733